Pay in 4 interest-free payments of $25.50 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
IHC analysis with anti-CD31 antibody shows that lenvatinib at 100 mg/kg decreases microvessel density more than anti-VEGF antibody and imatinib treatment
including renal cell carcinomas
thus indicating a potential application of SAE inhibitors in treating MYC-amplified tumors
InChiKey: CZGUSIXMZVURDU-JZXHSEFVSA-N
IMM-H007 nacipran IHC analysis with anti-CD31 antibodyIMM H007, an adenosine derivative, is an activator of AMP Activated Protein Kinase (AMPK). IMM H007 is a potential drug for treating cardiac dysfunction. IMM H007 negatively regulates endothelium inflammation through inactivating NF B and JNK AP1 signaling. IMM H007 inhibits ABCA1 (ATP binding cassette subfamily a member 1) degradation and facilitates its cell surface localization in macrophages, thereby promotes cholesterol efflux. Product
US$ 205.55
US$ 135.50
US$ 173.00
US$ 55.16
US$ 89.98
US$ 45.99
US$ 10.32
US$ 11.90
US$ 598.38
US$ 15.84